Fedorova, Yu Yu,
Sagitova, A.V.,
Mingazheva, E.T.,
Faishanova, R.R.,
Zagitov, I.R.,
Andreeva, E.A.,
Nurgalieva, A.Kh.,
Khusnutdinova, E.K.,
Darvish, M.,
Prokofyeva, D.S. (2024) from patients with an established diagnosis of ovarian
cancer and various histological and clinical
and in combination with cisplatin in a human ovarian
cancer xenograft model. Cisplatin was used as a comparator
With increasing incidence and geography,
cancer is one of the leading causes of death, reduced